Skip to main content
main-content
Erschienen in: Journal of Cancer Research and Clinical Oncology 7/2017

17.05.2017 | Letter to the Editor

Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment

verfasst von: Kiyotaka Nakamagoe, Tetuya Moriyama, Hiroshi Maruyama, Masahiro Yokosawa, Tadashi Hara, Shinya Tanaka, Manabu Fujimoto, Akira Tamaoka

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Excerpt

Editor, …
Literatur
Zurück zum Zitat Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71(4):484–492 CrossRefPubMedPubMedCentral Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71(4):484–492 CrossRefPubMedPubMedCentral
Zurück zum Zitat Jacob A, Unnikrishnan DC, Mathew A, Thyagarajan B, Patel S (2016) A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody use. J Cancer Res Clin Oncol 142(8):1869–1870 CrossRefPubMed Jacob A, Unnikrishnan DC, Mathew A, Thyagarajan B, Patel S (2016) A case of fatal Guillain–Barre syndrome from anti-PD1 monoclonal antibody use. J Cancer Res Clin Oncol 142(8):1869–1870 CrossRefPubMed
Zurück zum Zitat Kimura T, Fukushima S, Miyashita A et al (2016) Myasthenic crisis and polymyositis induced by one dose of nivolumab. Cancer Sci 107(7):1055–1058 CrossRefPubMedPubMedCentral Kimura T, Fukushima S, Miyashita A et al (2016) Myasthenic crisis and polymyositis induced by one dose of nivolumab. Cancer Sci 107(7):1055–1058 CrossRefPubMedPubMedCentral
Zurück zum Zitat Larkin J, Hodi FS, Wolchok JD (2015) Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373(13):1270–1271 CrossRefPubMed Larkin J, Hodi FS, Wolchok JD (2015) Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373(13):1270–1271 CrossRefPubMed
Zurück zum Zitat Wang C, Thudium KB, Han M et al (2014) In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res 2(9):846–856 CrossRefPubMed Wang C, Thudium KB, Han M et al (2014) In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res 2(9):846–856 CrossRefPubMed
Metadaten
Titel
Polymyalgia rheumatica in a melanoma patient due to nivolumab treatment
verfasst von
Kiyotaka Nakamagoe
Tetuya Moriyama
Hiroshi Maruyama
Masahiro Yokosawa
Tadashi Hara
Shinya Tanaka
Manabu Fujimoto
Akira Tamaoka
Publikationsdatum
17.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2017
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2410-x

Weitere Artikel der Ausgabe 7/2017

Journal of Cancer Research and Clinical Oncology 7/2017 Zur Ausgabe

Neu im Fachgebiet Onkologie

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.